Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra Rebouissou

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Journal of Hepatology|January 20, 2020
Advances in molecular classification and precision oncology in hepatocellular carcinomaSandra Rebouissou, Jean-Charles Nault
Journal of Hepatology|November 13, 2007
Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenomaSandra Rebouissou, Paulette Bioulac-Sage, Jessica Zucman-Rossi
Nature Reviews. Gastroenterology & Hepatology|June 30, 2019
The role of telomeres and telomerase in cirrhosis and liver cancerJean-Charles Nault, Massih Ningarhari, Sandra Rebouissou, et al.
BMC Cancer|October 7, 2011
HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell linesLaura Pelletier, Sandra Rebouissou, Danijela Vignjevic, et al.
Cancer Research|August 5, 2015
A Modeling Approach to Explain Mutually Exclusive and Co-Occurring Genetic Alterations in Bladder TumorigenesisElisabeth Remy, Sandra Rebouissou, Claudine Chaouiya, et al.
World Journal of Gastroenterology|June 15, 2007
Genotype phenotype classification of hepatocellular adenomaPaulette Bioulac-Sage, Jean Frédéric Blanc, Sandra Rebouissou, et al.
Hepatology (Baltimore, Md.)|April 25, 2008
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutationsYannick Ladeiro, Gabrielle Couchy, Charles Balabaud, et al.
Hepatology (Baltimore, Md.)|December 31, 2009
Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesisLaura Pelletier, Sandra Rebouissou, Alain Paris, et al.
Journal of Hepatology|May 10, 2008
The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodulesSandra Rebouissou, Gabrielle Couchy, Louis Libbrecht, et al.
Molecular & Cellular Oncology|June 17, 2016
Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancersThierry Lebret, Yann Neuzillet, Nadine Houede, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of Hepatology|January 20, 2020
Advances in molecular classification and precision oncology in hepatocellular carcinomaSandra Rebouissou, Jean-Charles Nault
Journal of Hepatology|November 13, 2007
Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenomaSandra Rebouissou, Paulette Bioulac-Sage, Jessica Zucman-Rossi
Nature Reviews. Gastroenterology & Hepatology|June 30, 2019
The role of telomeres and telomerase in cirrhosis and liver cancerJean-Charles Nault, Massih Ningarhari, Sandra Rebouissou, et al.
BMC Cancer|October 7, 2011
HNF1α inhibition triggers epithelial-mesenchymal transition in human liver cancer cell linesLaura Pelletier, Sandra Rebouissou, Danijela Vignjevic, et al.
Cancer Research|August 5, 2015
A Modeling Approach to Explain Mutually Exclusive and Co-Occurring Genetic Alterations in Bladder TumorigenesisElisabeth Remy, Sandra Rebouissou, Claudine Chaouiya, et al.
World Journal of Gastroenterology|June 15, 2007
Genotype phenotype classification of hepatocellular adenomaPaulette Bioulac-Sage, Jean Frédéric Blanc, Sandra Rebouissou, et al.
Hepatology (Baltimore, Md.)|April 25, 2008
MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutationsYannick Ladeiro, Gabrielle Couchy, Charles Balabaud, et al.
Hepatology (Baltimore, Md.)|December 31, 2009
Loss of hepatocyte nuclear factor 1alpha function in human hepatocellular adenomas leads to aberrant activation of signaling pathways involved in tumorigenesisLaura Pelletier, Sandra Rebouissou, Alain Paris, et al.
Journal of Hepatology|May 10, 2008
The beta-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodulesSandra Rebouissou, Gabrielle Couchy, Louis Libbrecht, et al.
Molecular & Cellular Oncology|June 17, 2016
Identification of targeted therapy for an aggressive subgroup of muscle-invasive bladder cancersThierry Lebret, Yann Neuzillet, Nadine Houede, et al.
Pageof 5